Iluzanebart
Based on 1 Customer Validation
Iluzanebart is a human monoclonal IgG1 antibody and is the agonist antibody for human TREM2 (hTREM2). Iluzanebart improves the survival and function of microglia by activating the TREM2 signaling pathway to compensate for the loss of CSF1R function. Iluzanebart can be used for research of adult-onset leukoencephalopathy associated with CSF1R (colony stimulating factor 1 receptor) (CSF1R-ALSP).
For research use only. We do not sell to patients.
- Purity: 98.63%
- CAS No.: 2733621-19-5
- Molecular Weight:144.92 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
TREM-2
In Vitro
Iluzanebart (0.1 nM-1 μM, 45 min) activates the TREM2 signaling pathway, increases the phosphorylation of SYK and DAP12 in cells HEK293T, hMDM and iMGL (EC50 for SYK phosphorylation in HEK293T, hMDM and iMGL is 0.27 nM, 4.77 nM and 0.63 nM, respectively)[1].
Iluzanebart (10 µg/mL, 48-96 h) restores PLX5622 (HY-114153)-induced cellular confluence and ramified morphology of cells hMDM and iMGL, and increases the cell viability[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:hMDM and iMGL
-
Concentration:10 µg/mL
-
Incubation Time:48-96 h
-
Result:Increased PLX5622-inhibited cell viability.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Human TREM2 expressing transgenic mice models[1]
-
Dosage:1-200 mg/kg
-
Administration:ip, single dose
-
Result:Increased the number of Ki67 positive microglia, the mean fluorescence intensity (MFI) of microglia with high CSF1R levels and the protein levels of specific chemokines such as IP10 and MIP1α.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Gene ID
Accession
Q9NZC2-1
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized TREM-2 Protein, Human can bind Iluzanebart. The EC50 for this effect is 178.6 ng/mL. -
Flow cytometric analysis of 1.5×106 THP-1 cells with Iluzanebart (HY-P990043, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS No. 2733621-19-5
-
Appearance Liquid
-
Molecular Weight 144.92 kDa
-
Color Colorless to light yellow
-
SMILES
[Iluzanebart]
-
Synonyms
VGL101
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (260 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)